Onconase: Will start Phase III trials in 200 patients within three months, in combination with tamoxifen; the end point will be survival

Alfacell Corp. (ACEL), Bloomfield, N.J. Product: Onconase, pancreatic ribonuclease that degrades RNA in cancer cells Indication: Pancreatic cancer Status: Will start Phase III trials in 200 patients...